|1.||Belcaro, Gianni: 1 article (12/2015)|
|2.||Miasnikova, M O: 1 article (01/2012)|
|3.||Vasilevich, V V: 1 article (01/2010)|
|4.||Tsukanov, A Iu: 1 article (01/2010)|
|5.||Tsukanov, Iu T: 1 article (01/2010)|
|6.||Belentsov, S M: 1 article (01/2007)|
|7.||Gudymovich, V G: 1 article (01/2006)|
|8.||Stoĭko, Iu M: 1 article (01/2006)|
|9.||Vix, J M: 1 article (02/2000)|
|10.||Peil, H: 1 article (02/2000)|
|1.||Lymphedema (Milroy Disease)
01/01/2012 - "The obtained results demonstrated undoubted efficacy of Antistax administered at early stages of postmastectomic lymphedema. "
01/01/2012 - "Analysed herein are the results of two-year treatment with Antistax of 50 female patients presenting with early stages of upper limb lymphedema (the 'preclinical' stage of 'transient' oedemas, mild-oedema stage). "
01/01/2010 - "It was determined that administration of Antistax at daily doses of 360 and 720 mg for 2 months resulted in a significant decrease in the volume of the affected extremity, which was accompanied by regression of complaints related to venous insufficiency. "
01/01/2007 - "It was shown that Antistax attenuates main symptoms of chronic venous insufficiency and improves the quality of life."
01/01/2006 - "[Pathophysiological mechanisms of lower limb chronic venous insufficiency and possibility of its correction with Antistax]."
12/01/2015 - "This 8-week registry study was a comparative evaluation of Pycnogenol (French Maritime Pine Bark extract; Horphag Research, Geneva) and Antistax (grape leaf extract [GLE, Boehringer Ingelheim, Germany]) in controlling symptoms of chronic venous insufficiency (CVI). "
12/01/2015 - "A Clinical Comparison of Pycnogenol, Antistax, and Stocking in Chronic Venous Insufficiency."